Ledger.Open graph →
SEC Form D · filed September 17, 2021

Biolinq Inc

Offering
$109.5M
Sold
$62.2M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
SAN DIEGO, CA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (17)

Richard Yang · San Diego, CAExec · DirectorNancy Hong · San Diego, CADirectorThad Johnson · San Diego, CADirectorJared Tangney · San Diego, CAExecDan Bradbury · San Diego, CADirectorJoshua Windmiller · San Diego, CAExecJohn D. Nichols · Palm Beach, FLExecMichael H. Jones · EUGENE, ORDirectorLuke V. Strgar · EUGENE, ORDirectorStephen J. Rooney · Queenstown, Q2DirectorTom H. Zelenovic · EUGENE, ORExec · DirectorPeter Travers · Longwood, FLDirectorRichard W. Rosenfield, M.D · Portland, ORExecRobert Garrison Ii · Houston, TXDirectorSteve Goodbarn · Denver, CODirectorElder Granger · Denver, COExec · DirectorJoshua Windmiller · San Diego, CAExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗